Updating results

11 results for faecal incontinence

Sort: Relevance | Date

Secca System for faecal incontinence (MIB66)

Advice on the use of the Secca system for treating faecal incontinence to aid local decision-making

Medtech innovation briefing Published May 2016

Axonics sacral neuromodulation system for overactive bladder and faecal incontinence (MIB164)

Advice on the use of Axonics sacral neuromodulation system (SNM) for overactive bladder and faecal incontinence to aid local decision-making

Medtech innovation briefing Published December 2018

Permacol for treating anal fistulae (MIB105)

Advice on the use of Permacol for treating anal fistulae (fistula) to aid local decision-making

Medtech innovation briefing Published May 2017

VAAFT for treating anal fistulae (MIB102)

Advice on the use of VAAFT for treating anal fistulae to aid local decision-making

Medtech innovation briefing Published April 2017

Episcissors-60 for guided mediolateral episiotomy (MIB33)

Advice on the use of the Episcissors-60 for guided mediolateral episiotomy to aid local decision-making

Medtech innovation briefing Published July 2015

Acute diarrhoea in adults: racecadotril (ESNM11)

Summary of the evidence on racecadotril for treating acute diarrhoea in adults to inform local NHS planning and decision-making

Evidence summary Published March 2013

Bile acid malabsorption: colesevelam (ESUOM22)

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

Pouchitis: rifaximin (ESUOM30)

Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making

Evidence summary Published March 2014

BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)

Advice on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume to aid local decision-making

Medtech innovation briefing Published January 2016

Scleroderma: oral mycophenolate (ESUOM32)

Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making

Evidence summary Published July 2014

Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment (ESUOM7)

Summary of the evidence on 0.2% topical glyceryl trinitrate ointment for chronic anal fissure to inform local NHS planning and decision-making

Evidence summary Published March 2013